BIIB vs VTR · P/E 21, rev $9.89B vs P/E 149, rev $1.73B
Biogen Inc (BIIB) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported VTR revenue for 2026-06-30 was $1.73B. Net income was $72.2M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the BIIB and VTR stock pages for the full models.
Not investment advice.